BPTS - Biophytis and Skyepharma form Partnership for Sarconeos (BIO101) Production

2023-09-25 07:27:53 ET

(24/7 MARKET NEWS) – Biophytis SA (NASDAQ:BPTS) and Skyepharma, a French pharmaceutical company, stated, this morning, that they signed a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19, to submit for marketing authorization applications.

Biophytis is trading at $1.19, up $0.3009 (+35.21%), on 1.25M premarket shares traded.

Its 52-week range is $0.8801 to $9.024. The gap from $1.28 to $1.38 should refill and most of its resistance is low volume, so this may have legs today.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is …

The post Biophytis and Skyepharma form Partnership for Sarconeos (BIO101) Production appeared first on 24/7 Market News .

For further details see: